Etodolac Capsule
NDC Package 83980-032-13

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Etodolac capsules is etodolac is used to relieve pain from various conditions. This formulation utilizes a capsule delivery system. Marketed by Ipca Laboratories Limited, this product is identified by NDC 83980-032 and is authorized under FDA application ANDA205448.

Identification & Billing

NDC Package Code
83980-032-13
Package Description
30 CAPSULE in 1 BOTTLE
Product Code
83980-032
11-Digit Billing Format
83980003213
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Etodolac
Non-Proprietary Name
Etodolac
Substance Name
Etodolac
Dosage Form
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
ETODOLAC 300 mg/1
Pharmacologic Class
Usage Information
Etodolac is used to relieve pain from various conditions. It also reduces pain, swelling, and joint stiffness from arthritis. This medication is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section.

Regulatory & Marketing

Labeler Name
Ipca Laboratories Limited
Product Type
Human Prescription Drug
FDA Application #
ANDA205448
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-06-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (83980-032). Click a package code to view its specific billing and regulatory data.

83980-032-01
100 CAPSULE in 1 BOTTLE
83980-032-05
500 CAPSULE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83980-032-13 identifies a specific commercial package of 30 capsule in 1 bottle of Etodolac, a human prescription drug labeled by Ipca Laboratories Limited. This capsule is formulated for oral use and contains etodolac as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ipca Laboratories Limited on February 06, 2026. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

Etodolac is used to relieve pain from various conditions. It also reduces pain, swelling, and joint stiffness from arthritis. This medication is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section.

How is this Ipca Laboratories Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83980003213. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
83980-032-13
11-Digit CMS (5-4-2)
83980-0032-13

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.